Prüftechnik ShaftAlign Touch Laser Alignment System Enables Technicians to Quickly and Precisely Align the Majority of Standard Machines
16.9.2020 13:00:00 EEST | Business Wire | Press release
Prüftechnik, a division of Fluke Reliability, introduces the ShaftAlign Touch laser alignment system, a new digital solution that exceeds the capabilities of conventional tools and delivers greater speed and accuracy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200916005134/en/
The user-friendly system combines premium single-laser technology with Active Situational Intelligence to empower teams of varying experience levels to align most any asset with new levels of precision and speed. (Photo: Business Wire)
The user-friendly system combines premium single-laser technology with Active Situational Intelligence to empower teams of varying experience levels to align most any asset with new levels of precision and speed. Prüftechnik Adaptive Alignment systems, such as the ShaftAlign Touch, automatically eliminate user errors and low-quality measurement points by adapting to the asset, the alignment situation, and the technician who is performing the job. Cloud-compatible software allows newer technicians to share measurements with more experienced colleagues or consultants — inside the plant or across the globe — to complete a job.
“ShaftAlign Touch is a significant improvement over conventional shaft alignment measurement equipment and basic laser systems in the market,” said Ankush Malhotra, vice president and general manager of Fluke Reliability. “With its intuitive computer-based, guided user interface, single-laser technology, and cloud-transfer capabilities, ShaftAlign Touch, sets a new benchmark for solving alignment issues at an unbeatable price/performance ratio.”
ShaftAlign Touch delivers:
- High performance and precise results — ShaftAlign Touch leverages single-laser technology to provide high-precision, high-performance alignment measurements.
- Quick setup and intuitive user interface — its swift setup and tablet-like, intuitive guided user interface make it more user-friendly than any of the conventional alignment measurement methods.
- Ability to share data via the cloud — technicians can leverage its integrated Wi-Fi cloud solution to easily transfer measurement data from the ShaftAlign Touch handheld device to the ARC 4.0 software.
ShaftAlign Touch is the latest addition to the family of Prüftechnik Adaptive Alignment laser systems. Adaptive Alignment is a combination of software and hardware that enables maintenance and reliability teams to adjust to most any horizontal, angular, or vertical alignment challenge. With Adaptive Alignment solutions, work is completed faster, results are more accurate, and team capabilities are better utilized compared to other market solutions.
For more information on the Prüftechnik ShaftAlign Touch, visit https://www.pruftechnik.com/en-US/Products-and-Services/Alignment-Systems-for-Rotating-Machinery/Shaft-Alignment/Shaft-Alignment-Systems/SHAFTALIGN-touch/.
About Prüftechnik
Prüftechnik is a worldwide provider of maintenance technology with a comprehensive product, service, and training program tailored to the needs of maintenance experts in shaft alignment, vibration analysis, condition monitoring, and destruction-free testing. Many manufacturing companies worldwide trust its solutions for reliable and condition-based maintenance of rotating machines. For more information, visit https://www.pruftechnik.com.
About Fluke Reliability
Fluke Reliability offers reliability and maintenance teams the tools, software, and services they need to optimize asset performance. Home to three powerful iconic brands – Prüftechnik, eMaint, and Fluke Connect – Fluke Reliability serves more than 70,000 customers worldwide with a relentless dedication to quality, innovation, and service. Its products inform customers on the health of their assets, and its software and services drive better maintenance decisions – improving productivity, driving uptime, and reducing costs. For more information, visit https://www.accelix.com.
FLUKE is a registered trademark of Fluke Corporation. For more information, visit the Fluke website.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200916005134/en/
Contact information
Barbara Ellis
(425) 446-4949
barbara.ellis@fluke.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom